Repertoire Immune Medicines

Repertoire Immune Medicines is a biotechnology company dedicated to developing transformative and programmable immune medicines for patients with cancer and autoimmune diseases. They leverage their proprietary DECODE platform, a suite of experimental and computational technologies, to decode the immune synapse, the central hardware of the adaptive immune system. This allows them to discover unique immune codes and design medicines that precisely target disease-relevant epitopes, ultimately programming the immune system to fight disease.

Repertoire is developing two distinct off-the-shelf therapeutic approaches for cancer: TCR bispecific immune medicines and mRNA cancer vaccines. For autoimmune diseases, they are developing mRNA tolerizing vaccines that aim to re-establish immune homeostasis, leading to durable disease remission. They are currently developing these therapies for a range of diseases including non-small cell lung cancer, triple-negative breast cancer, type 1 diabetes and multiple sclerosis.

Repertoire Immune Medicines is a biotechnology company committed to developing novel and programmable immune medicines for patients with cancer and autoimmune diseases. They aim to unlock the unique codes within the body's T cell repertoire and use this knowledge to create targeted therapies that either selectively eliminate tumors or restore immune balance, providing new hope for patients with limited treatment options.

Repertoire Immune Medicines cultivates a collaborative and inclusive culture driven by a shared passion for translating their science into life-saving medicines. They prioritize a sense of urgency in their mission, accountability for individual contributions, and a strong team ethos. The company values creativity, ingenuity, and the diversity of its workforce, recognizing that a diverse team is essential for achieving their goals and creating impactful treatments for those in need.

Repertoire Immune Medicines is committed to building an inclusive culture that reflects the diversity of the immune system. They acknowledge and dismantle biases in their systems, support community initiatives, and offer educational opportunities and paid internships to students. Their goal is to create an environment where the creativity and ingenuity of a diverse workforce can contribute to their mission of developing innovative immune medicines.